Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06411665Phase 4Completed
A Phase 4 trial of oliceridine in postoperative nausea and vomiting (PONV), postoperative pain, sponsored by Peking University First Hospital. Started Jul 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06411665.